Ocular Therapeutix, Inc. (OCUL)
11.12
-0.30
(-2.67%)
USD |
NASDAQ |
Jan 22, 16:00
11.21
+0.10
(+0.85%)
After-Hours: 20:00
Ocular Therapeutix Total Assets (Quarterly): 410.88M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | 42.71B |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| Dynavax Technologies Corp. | 946.51M |
| Vertex Pharmaceuticals, Inc. | 24.86B |
| Krystal Biotech, Inc. | 1.240B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 152.65M |
| Shareholders Equity (Quarterly) | 258.23M |
| Debt to Equity Ratio | 0.2982 |
| Current Ratio | 7.850 |
| Net Debt Paydown Yield | -0.02% |